Cargando…
Statin use in patients with non‐HMGCR idiopathic inflammatory myopathies: A retrospective study
BACKGROUND: Statins are the most widely used lipid lowering therapies which reduce cardiovascular risk, but are associated with muscular adverse events (AEs). Idiopathic inflammatory myopathies (IIM) are autoimmune diseases of the muscle with higher risk of cardiovascular disease. More data is neede...
Autores principales: | Bae, Sangmee Sharon, Oganesian, Buzand, Golub, Ilana, Charles‐Schoeman, Christina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368310/ https://www.ncbi.nlm.nih.gov/pubmed/32432360 http://dx.doi.org/10.1002/clc.23375 |
Ejemplares similares
-
Anti-HMGCR Myopathy
por: Mohassel, Payam, et al.
Publicado: (2018) -
Anti-HMGCR Myopathy without Exposure to Statins: A Case Report
por: Ferriz Vivancos, Jorge, et al.
Publicado: (2022) -
Assessment of antibody levels to SARS-CoV-2 in patients with idiopathic inflammatory myopathies receiving treatment with intravenous immunoglobulin
por: Bae, Sangmee Sharon, et al.
Publicado: (2023) -
Anti-HMGCR Autoantibodies in European Patients With Autoimmune Necrotizing Myopathies: Inconstant Exposure to Statin
por: Allenbach, Yves, et al.
Publicado: (2014) -
Unusual Skin Involvement in Statin-induced Anti-HMGCR Immune-mediated Necrotizing Myopathy
por: SCARD, Camille, et al.
Publicado: (2021)